Black ginseng extract ameliorates hypercholesterolemia in rats

[1]  Sung Dae Kim,et al.  Antiatherosclerotic Effect of Korean Red Ginseng Extract Involves Regulator of G-Protein Signaling 5 , 2014, Evidence-based complementary and alternative medicine : eCAM.

[2]  Jong-Hoon Kim,et al.  A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases , 2014, Journal of ginseng research.

[3]  U. Landmesser,et al.  The Year in Cardiology 2013: cardiovascular disease prevention. , 2014, European heart journal.

[4]  Jun Liu,et al.  Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease[S] , 2013, Journal of Lipid Research.

[5]  Hyun In Oh,et al.  Anti-obesity effects of black ginseng extract in high fat diet-fed mice , 2013, Journal of ginseng research.

[6]  O. Wiest,et al.  Molecular modeling of the reaction pathway and hydride transfer reactions of HMG-CoA reductase. , 2012, Biochemistry.

[7]  C. Sung,et al.  Comparative Study of White and Steamed Black Panax ginseng, P. quinquefolium, and P. notoginseng on Cholinesterase Inhibitory and Antioxidative Activity , 2012, Journal of ginseng research.

[8]  Jong-Hoon Kim,et al.  Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical Applications , 2012, Journal of ginseng research.

[9]  C. Sung,et al.  Comparative Study of Korean White, Red, and Black Ginseng Extract on Cholinesterase Inhibitory Activity and Cholinergic Function , 2011, Journal of ginseng research.

[10]  M. Eriksson,et al.  ACAT2 and human hepatic cholesterol metabolism: identification of important gender-related differences in normolipidemic, non-obese Chinese patients. , 2009, Atherosclerosis.

[11]  Subhashish Banerjee,et al.  Green and black tea extracts inhibit HMG-CoA reductase and activate AMP kinase to decrease cholesterol synthesis in hepatoma cells. , 2009, The Journal of nutritional biochemistry.

[12]  Mats Eriksson,et al.  ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver , 2004, Circulation.

[13]  J. Tobert,et al.  Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors , 2003, Nature Reviews Drug Discovery.

[14]  H. Shimano.  Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. , 2001, Progress in lipid research.

[15]  L. Pilotto.  [Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[16]  R. Hammer,et al.  Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. , 1997, The Journal of clinical investigation.

[17]  B. Paigen,et al.  Variation in susceptibility to atherosclerosis among inbred strains of mice. , 1985, Atherosclerosis.

[18]  J. R. Beaton,et al.  Energy balance and obesity. , 1967, Canadian journal of public health = Revue canadienne de sante publique.

[19]  M. Washington,et al.  Tumorigenesis and Neoplastic Progression High Fat Diet Induced Hepatic Steatosis Establishes a Permissive Microenvironment for Colorectal Metastases and Promotes Primary Dysplasia in a Murine Model , 2010 .